Vaxcyte PCVX Balance Sheet (2019-2026)

NASDAQ PCVX
$68.62 +2.26 (+3.41%)
At close: Nov 11, 2026 · 4:00 PM EST
Reported Financials

Vaxcyte Quarterly Balance Sheet

Periods 31 quarters
Latest Sep 2026

Vaxcyte reported total assets of $2989.14M and total liabilities of $499.92M for the quarter ended Sep 2026, down 5.8% year over year. This balance sheet covers 31 quarters of results from Mar 2019 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Balance SheetBalance Sheet Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
68.99M201.74M238.17M278.40M834.66M380.45M531.03M545.13M397.45M611.51M518.67M1,050.19M387.88M346.85M306.74M281.08M173.96M260.84M183.19M125.47M
Short-term InvestmentsInvestments (Current)
176.99M132.90M116.33M83.83M96.72M441.59M756.03M720.55M682.78M875.01M934.03M1,130.28M1,359.33M1,324.88M1,354.68M1,430.24M1,387.00M1,476.34M1,303.65M1,166.76M
Cash & Current Investments
245.97M334.64M354.50M362.23M931.38M822.04M1,287.06M1,265.68M1,080.23M1,486.52M1,452.70M2,180.47M1,747.21M1,671.73M1,661.43M1,711.32M1,560.96M1,737.18M1,486.84M1,292.23M
Receivables - NetNet Receivables
Receivables - OtherOther Receivables
1.03M1.89M0.01M0.13M0.39M0.30M
Receivables
Current Deferred Tax AssetsCurrent Deferred Tax
Prepaid Assets
10.38M7.58M9.23M7.53M11.18M18.64M23.25M29.75M15.73M30.55M28.78M33.40M40.78M44.83M54.35M55.85M66.40M76.31M65.83M57.33M
Current Assets
256.35M342.22M363.73M369.76M942.56M840.67M1,310.32M1,295.43M1,095.95M1,517.07M1,481.48M2,213.87M1,787.99M1,716.56M1,715.78M1,767.17M1,627.36M1,813.49M1,552.67M1,349.56M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net)
7.95M10.14M10.18M9.95M10.36M15.21M16.42M11.43M79.63M84.84M125.97M163.24M198.05M217.16M242.27M253.49M257.37M260.70M260.39M253.36M
Long-Term Investments
27.12M17.70M6.86M3.98M26.55M127.82M153.73M168.56M162.68M413.25M399.24M1,092.57M1,387.51M1,279.03M1,165.09M959.26M881.66M1,004.02M1,020.90M972.16M
Other Non-Current Assets
4.96M7.41M7.17M6.37M0.87M5.68M5.22M5.40M1.10M1.10M1.10M1.32M66.99M1.32M1.32M1.47M120.31M158.47M195.49M5.75M
Non-Current Assets
67.99M60.49M47.89M42.31M63.62M167.49M192.50M200.62M311.96M574.23M605.79M1,345.88M1,723.33M1,661.54M1,589.59M1,404.43M1,375.36M1,534.82M1,585.49M1,639.58M
Assets
324.34M402.72M411.62M412.07M1,006.18M1,008.16M1,502.82M1,496.06M1,407.92M2,091.31M2,087.27M3,559.75M3,511.32M3,378.10M3,305.36M3,171.60M3,002.72M3,348.31M3,138.15M2,989.14M
Liabilities
Current Liabilities
Accounts Payables
6.76M4.80M7.04M5.49M9.80M11.62M16.27M15.70M14.59M21.72M10.47M18.22M48.45M20.51M31.41M48.96M70.90M63.06M100.92M67.61M
Payables
6.76M4.80M7.04M5.49M9.80M11.62M16.27M15.70M14.59M21.72M10.47M18.22M48.45M20.51M31.41M48.96M70.90M63.06M100.92M67.61M
Accumulated Expenses
8.79M7.74M9.89M13.68M15.38M18.35M19.18M15.02M59.82M54.17M22.15M30.75M29.12M26.04M32.21M24.59M31.07M30.25M24.73M30.62M
Other Accumulated Expenses
3.66M0.97M0.93M1.58M1.41M2.70M1.91M2.49M1.90M3.09M6.46M12.24M20.56M5.99M10.83M16.76M23.00M7.99M13.82M20.66M
Current Leases
5.91M7.11M10.92M
Current Deferred Revenue
5.28M5.91M
Total Current Liabilities
28.72M27.25M30.47M39.31M40.53M52.75M60.22M85.56M145.34M87.10M82.85M123.79M140.18M97.00M154.49M200.05M205.75M242.08M271.28M295.70M
Non-Current Liabilities
Capital Leases
96.86M
Preferred Stock Liabilities
Operating Leases
11.51M15.83M14.56M13.36M12.03M10.64M9.22M7.78M22.11M20.22M18.29M18.32M65.22M81.08M79.54M78.67M111.46M110.21M108.94M107.37M
Other Non-Current Liabilities
0.10M0.09M0.09M0.09M0.01M0.01M0.01M0.00M0.10M0.10M
Total Non-Current Liabilities
40.22M43.08M45.03M52.67M52.56M63.39M69.44M93.34M167.45M205.40M317.11M
Total Liabilities
40.32M43.17M45.12M52.75M52.57M63.39M69.44M93.34M167.45M107.32M101.14M142.11M205.50M178.08M234.03M278.72M317.21M352.29M380.21M499.92M
Shareholder's Equity
Common Equity
284.02M359.54M366.50M359.31M953.61M944.77M1,433.38M1,402.72M1,240.47M1,983.98M1,986.13M3,417.63M3,305.82M3,200.03M3,071.33M2,892.88M2,685.51M2,996.01M2,757.94M2,489.22M
Liabilities and Shareholders Equity
324.34M402.72M411.62M412.07M1,006.18M1,008.16M1,502.82M1,496.06M1,407.92M2,091.31M2,087.27M3,559.75M3,511.32M3,378.10M3,305.36M3,171.60M3,002.72M3,348.31M3,138.15M2,989.14M
Retained Earnings
-298.64M-337.63M-386.16M-444.08M-522.13M-582.59M-650.93M-743.59M-924.39M-1,019.41M-1,148.12M-1,251.24M-1,388.32M-1,529.04M-1,695.61M-1,908.44M-2,154.95M-2,475.57M-2,759.87M-3,056.93M

Vaxcyte Balance Sheet API

Pull Vaxcyte's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=PCVX&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY